STOCK INCENTIVE PLANS - Schedule of Components of Restricted Stock Units (Details) $ in Millions |
6 Months Ended |
|---|---|
|
Jun. 30, 2025
USD ($)
shares
| |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Unvested restricted stock units (in shares) | shares | 3,535,451 |
| Unrecognized compensation expense | $ 15 |
| Intrinsic value | $ 52 |
| Weighted average remaining life (in years) | 2 years 1 month 6 days |
| Service- Based Units | |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Unvested restricted stock units (in shares) | shares | 2,579,301 |
| Unrecognized compensation expense | $ 15 |
| Intrinsic value | $ 38 |
| Weighted average remaining life (in years) | 2 years 3 days |
| Performance- Based Units | |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Unvested restricted stock units (in shares) | shares | 956,150 |
| Unrecognized compensation expense | $ 0 |
| Intrinsic value | $ 14 |
| Weighted average remaining life (in years) | 2 years 4 months 2 days |
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|